Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

globenewswire.com - Zealand Pharma - Zealand Pharma - Transactions related to share buy-back program (week 22, 2026)
Zealand Pharma - Transactions related to share buy-back program (week 22, 2026)
GlobeNewswire

Company announcement No. 20 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 22, 2026) Copenhagen, Denmark, June 1, 2026 – Zealand Pharma A/S ('the Company' or “Zealand Pharma”) (Nasdaq: ZEAL)…

washingtonexaminer.com - Chadwick Hagan - Fixing American healthcare means fighting Big Pharma everywhere
Fixing American healthcare means fighting Big Pharma everywhere
Washington Examiner

As someone who has worked across business, finance, and healthcare, I have seen firsthand how rising drug costs spread far beyond the pharmacy counter. Too many policymakers are celebrating domestic pharmaceutical expansion while ignoring the…

forbes.com - Arun Ramakrishnan - Why Generic AI Agents Don't Work In Regulated Industries
Why Generic AI Agents Don't Work In Regulated Industries
Forbes

​Arun Ramakrishnan is co-founder and CTO of LogicFlo AI. Not long ago, when people interacted with AI systems, they were experiencing them as chatbots. You asked a question, got an answer, maybe asked a follow-up and that was the end of the…

marketbeat.com - Geode Capital Management LLC Purchases 502,582 Shares of BridgeBio Pharma, Inc. $BBIO
Geode Capital Management LLC Purchases 502,582 Shares of BridgeBio Pharma, Inc. $BBIO
MarketBeat

Geode Capital Management LLC increased its position in BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 12.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned…

marketbeat.com - Hillsdale Investment Management Inc. Acquires 23,700 Shares of Royalty Pharma PLC $RPRX
Hillsdale Investment Management Inc. Acquires 23,700 Shares of Royalty Pharma PLC $RPRX
MarketBeat

Hillsdale Investment Management Inc. lifted its holdings in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 5,266.7% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission…

marketbeat.com - Geode Capital Management LLC Acquires 102,430 Shares of Royalty Pharma PLC $RPRX
Geode Capital Management LLC Acquires 102,430 Shares of Royalty Pharma PLC $RPRX
MarketBeat

Geode Capital Management LLC boosted its holdings in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 1.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned…

thehindubusinessline.com - India-Oman CEPA takes effect: 98% duty-free access opens doors for textiles, pharma, MSMEs: Piyush Goyal
India-Oman CEPA takes effect: 98% duty-free access opens doors for textiles, pharma, MSMEs: Piyush Goyal
BusinessLine

Union Commerce and Industry Minister Piyush Goyal on Monday said that the India-Oman Comprehensive Economic Partnership Agreement (CEPA) that takes effect from today (June 1) will give Indian exporters immediate duty-free access to Oman and expand…

globenewswire.com - Nxera Pharma - Nxera's Vamorolone Granted Key Regulatory Designations Supporting Faster Access for Duchenne Muscular Dystrophy Patients in South Korea
Nxera's Vamorolone Granted Key Regulatory Designations Supporting Faster Access for Duchenne Muscular Dystrophy Patients in South Korea
GlobeNewswire

Orphan Drug Designation (ODD) recognizes Duchenne muscular dystrophy as a rare disease with significant unmet medical need without an established treatment in South Korea. Global Innovative Products on Fast Track (GIFT) designation, a priority…

cnbc.com - Jeff Marks - We're picking up more shares of an out-of-favor stock with a bright future
We're picking up more shares of an out-of-favor stock with a bright future
CNBC

We are buying 50 shares of Johnson & Johnson at roughly $221.43. Following the trade, Jim Cramer's Charitable Trust will own 340 shares of JNJ, increasing its weighting to 1.9% from 1.62%. We're picking up shares of J & J here and lowering our…

globenewswire.com - Santhera Pharmaceuticals Holding AG - Santhera Announces Orphan Drug and Priority Review Designations for AGAMREE (Vamorolone) in South Korea
Santhera Announces Orphan Drug and Priority Review Designations for AGAMREE (Vamorolone) in South Korea
GlobeNewswire

Pratteln, Switzerland, June 2, 2026 – Santhera Pharmaceuticals (SIX: SANN) today notes that AGAMREE has been granted Orphan Drug Designation (ODD) and Global Innovative Products on Fast Track (GIFT) designation by South Korea's Ministry of…

washingtonexaminer.com - Kaelan Deese - High-profile convicts lobby for rumored pardons tied to country's 250th birthday
High-profile convicts lobby for rumored pardons tied to country's 250th birthday
Washington Examiner

“The President is the final decider on all pardons or commutations,” the official added. Still, the mere possibility of looming pardons has already triggered sharp interest from figures such as Martin Shkreli, whose decision to raise…

forbes.com - David Talby - Why Central AI Governance Committees Are Failing Healthcare-And Their Fix
Why Central AI Governance Committees Are Failing Healthcare-And Their Fix
Forbes

David Talby, PhD, MBA, CEO at John Snow Labs. Solving real-world problems in healthcare, life sciences and related fields with AI. ​A new institutional fixture has emerged across healthcare: the AI governance committee. From academic medical…

afr.com - Timothy Moore - Wall St rallies, oil pares earlier spike, on Middle East peace hopes
Wall St rallies, oil pares earlier spike, on Middle East peace hopes
Australian Financial Review

Australian share futures were lower near 4am AEST, though they had pared earlier losses and were poised to turn high in line with a sharp reversal on Wall Street. The turnaround was sparked by a social media post by President Donald Trump that…

dailyreckoning.com - Adam Sharp - The China Threat to… Everything
The China Threat to… Everything
Daily Reckoning

In the 1980s and ‘90s, China was among the poorest countries in the world. More than 90% of the country's population lived in extreme poverty in the early ‘80s. In one of the most remarkable growth stories in history, the country has…

semafor.com - J.D. Capelouto - China's biotech boom alarms Western lawmakers, investors
China's biotech boom alarms Western lawmakers, investors
Semafor

China's ascendance in biotech is raising alarm bells among some lawmakers and investors in the West. Eli Lilly entered into its latest agreement with a Chinese drugmaker Monday, while Pfizer last week announced a tie-up with a Chinese firm to…

Receive a Daily briefing on Pharma Industry News

Get Started